Brief: Japan Tobacco Says Agrees To Discuss Terminating Licence Agreements For 6 Anti-Hiv Drugs With Gilead Sciences
Aug 27 (Reuters) - Japan Tobacco Inc 2914.T :
* JAPAN TOBACCO SAYS AGREES TO DISCUSS TERMINATING LICENCE
AGREEMENTS FOR 6 ANTI-HIV DRUGS WITH GILEAD SCIENCES GILD.O
* JAPAN TOBACCO SAYS GILEAD TOLD JT IT WOULD MANAGE
REGULATORY
APPROVAL PROCESS, MARKETING IN JAPAN THROUGH ITS OWN LOCAL UNIT
Source text for Eikon: ID:nNDLbDbL3f
Further company coverage: 2914.T GILD.O
Recent news on Torii Pharmaceutical Co
See all newsTable: Torii Pharmaceutical - 6-MTH parent results
Brief: Torii Pharmaceutical Co Ltd Says It Will Retire Treasury Shares Worth 2.39% Of Outstanding Stock On Aug 29
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Drugmaker Shionogi to buy Japan Tobacco's unit Torii Pharmaceutical for $1 billion (updated)